Protagonist Therapeutics
PTGX
PTGX
38 hedge funds and large institutions have $175M invested in Protagonist Therapeutics in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
21% more capital invested
Capital invested by funds: $145M → $175M (+$30.2M)
12% more funds holding
Funds holding: 34 → 38 (+4)
Holders
38
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$8.32M | |
| 2 | +$3.69M | |
| 3 | +$1.36M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$834K |
| 5 |
State Street
Boston,
Massachusetts
|
+$683K |
Top Sellers
| 1 | -$7.92M | |
| 2 | -$1.76M | |
| 3 | -$1.72M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$1.31M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.1M |